An Efficient and Ultrasensitive NGS Solution for Profiling ctDNA [Poster Talk Video]

SeraCare Customer Poster Talk Video with Data Presented by Asuragen

Next-generation sequencing (NGS) of liquid biopsies offers a minimally invasive alternative to solid tissue biopsies and a more holistic profile of intra- and inter-tumoral heterogeneity for therapy selection and disease monitoring. 

Watch the video and download this free poster to learn:

• How reference materials that commute to the target sample type can help to optimize ctDNA profiling technology
• Why the Seraseq ctDNA v2 Reference Material most closely resembles native ctDNA in amplifiablity and molecular diversity
• How highly patient-like reference materials allowed confident quantification of trace levels of ctDNA 

We developed a technology that is able to quantify these trace levels of ctDNA. And we were able to do so because we optimized around a standard that we were confident in—that represented the targeted sample type.

~ Brian C. Haynes, Associate Director of Bioinformatics – Asuragen